Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M1MZ
|
|||
| Former ID |
DIB010150
|
|||
| Drug Name |
Reviroc
|
|||
| Synonyms |
TH-9401; Antileukemics (photoactive), Theratechnologies; Tumor cell depletion therapy (hematological cancers), Kiadis
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | B-cell lymphoma [ICD-11: 2A86; ICD-10: C85.1; ICD-9: 202.8] | Phase 2 | [1] | |
| Company |
Theratechnologies Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H15Br2ClN2O3
|
|||
| Canonical SMILES |
COC(=O)C1=CC=CC=C1C2=C3C=CC(=N)C(=C3OC4=C2C=CC(=C4Br)N)Br.Cl
|
|||
| InChI |
1S/C21H14Br2N2O3.ClH/c1-27-21(26)11-5-3-2-4-10(11)16-12-6-8-14(24)17(22)19(12)28-20-13(16)7-9-15(25)18(20)23;/h2-9,24H,25H2,1H3;1H
|
|||
| InChIKey |
MUDCDMMNYVJLEB-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 174230-05-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02519816) Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.